While Advair’s price cutting and competition pegged back GSK’s respiratory sales overall, there were some bright spots, including COPD triple therapy Trelegy which made £156 million in its ...

The factory is located in a suburb of Kampala and is the first in Africa to produce full triple-therapy generic ARVs. The factory is expected to produce 600 million tablets per year. A prospective ...